Paper
24 April 2009 Preparation of lisinopril-capped gold nanoparticles for molecular imaging of angiotensin-converting enzyme
Yuan Li, Cesar Baeta, Omer Aras, Marie-Christine Daniel
Author Affiliations +
Abstract
Overexpression of angiotensin-converting enzyme (ACE) has been associated with the pathophysiology of cardiac and pulmonary fibrosis. Moreover, the prescription of ACE inhibitors, such as lisinopril, has shown a favorable effect on patient outcome for patients with heart failure or systemic hypertension. Thus targeted imaging of the ACE would be of crucial importance for monitoring tissue ACE activity as well as the treatment efficacy in heart failure. In this respect, lisinopril-coated gold nanoparticles were prepared to provide a new type of probe for targeted molecular imaging of ACE by tuned K-edge computed tomography (CT) imaging. The preparation involved non-modified lisinopril, using its primary amine group as the anchoring function on the gold nanoparticles surface. The stable lisinopril-coated gold nanoparticles obtained were characterized by UV-vis spectroscopy, dynamic light scattering (DLS), transmission electron microscopy (TEM). Their zeta potential was also measured in order to assess the charge density on the modified gold nanoparticles (GNPs).
© (2009) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Yuan Li, Cesar Baeta, Omer Aras, and Marie-Christine Daniel "Preparation of lisinopril-capped gold nanoparticles for molecular imaging of angiotensin-converting enzyme", Proc. SPIE 7313, Smart Biomedical and Physiological Sensor Technology VI, 731304 (24 April 2009); https://doi.org/10.1117/12.818226
Lens.org Logo
CITATIONS
Cited by 1 scholarly publication.
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Gold

Nanoparticles

Transmission electron microscopy

Particles

Molecules

Absorption

Tissues

Back to Top